TriSalus Life Sciences, Inc. Common Stock (TLSI) Stock Price

TLSIStock

$3.63−23.58%52W

Market Cap$223.52M

P/E—

PEG Ratio—

Div yield—

Beta0.47

TLSI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-27.41%

Price vs S&P 500 (4W)-25.78%

VGM Score39.63

Book Value / Share (Quarterly)$0.11

P/TBV (Annual)16.11x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.38

Price vs S&P 500 (YTD)-59.92%

Gross Margin (TTM)85.79%

Net Profit Margin (TTM)-62.59%

EPS (TTM)$-0.59

10-Day Avg Trading Volume0.17M

EPS Excl Extra (TTM)$-0.59

EPS (Annual)$-1.04

ROI (Annual)71.03%

Gross Margin (Annual)84.57%

Cash / Share (Quarterly)$0.75

Revenue Growth QoQ (YoY)1.73%

ROA (Last FY)-111.03%

Revenue Growth TTM (YoY)25.25%

EBITD / Share (TTM)$-0.60

Operating Margin (TTM)-67.68%

Cash Flow / Share (Annual)$-0.38

P/B Ratio34.12x

P/B Ratio (Quarterly)42.66x

Net Income / Employee (Annual)$-384,600

EV / Revenue (TTM)4.67x

Net Interest Coverage (TTM)-6.86x

ROA (TTM)-54.99%

EPS Incl Extra (Annual)$-1.04

Current Ratio (Annual)2.80x

Quick Ratio (Quarterly)4.72x

3-Month Avg Trading Volume0.33M

52-Week Price Return-23.58%

EV / Free Cash Flow (Annual)19.22x

Revenue / Employee (TTM)$441,900

Tangible BV / Share (Quarterly)$0.28

P/S Ratio (Annual)4.95x

Asset Turnover (Annual)1.28x

52-Week High$7.95

EPS Excl Extra (Annual)$-1.04

26-Week Price Return-17.50%

Quick Ratio (Annual)2.35x

13-Week Price Return-15.38%

Total Debt / Equity (Annual)0.20x

Current Ratio (Quarterly)5.35x

Enterprise Value$210.29M

Asset Turnover (TTM)0.88x

Revenue / Employee (Annual)$442,700

Pretax Margin (Annual)-86.86%

Cash / Share (Annual)$0.41

3-Month Return Std Dev54.66%

Net Income / Employee (TTM)$-276,600

ROE (Last FY)85.23%

Net Interest Coverage (Annual)-4.79x

EPS Basic Excl Extra (Annual)$-1.04

Receivables Turnover (TTM)7.49x

EV / Free Cash Flow (TTM)46.64x

Total Debt / Equity (Quarterly)5.05x

EPS Incl Extra (TTM)$-0.59

ROI (TTM)-17.89%

P/S Ratio (TTM)4.96x

Revenue / Share (Annual)$1.19

Tangible BV / Share (Annual)$0.80

Price vs S&P 500 (52W)-39.11%

Year-to-Date Return-47.99%

5-Day Price Return-12.32%

EPS Normalized (Annual)$-1.04

ROA (5Y Avg)-89.67%

Net Profit Margin (Annual)-86.88%

Month-to-Date Return-15.78%

Cash Flow / Share (TTM)$0.09

EBITD / Share (Annual)$-0.69

Operating Margin (Annual)-59.68%

LT Debt / Equity (Annual)0.20x

LT Debt / Equity (Quarterly)5.05x

EPS Basic Excl Extra (TTM)$-0.59

P/TBV (Quarterly)17.74x

P/B Ratio (Annual)5.02x

Inventory Turnover (TTM)1.60x

Pretax Margin (TTM)-62.56%

Book Value / Share (Annual)$0.80

Price vs S&P 500 (13W)-18.07%

Beta0.47x

Revenue / Share (TTM)$0.77

ROE (TTM)-79.02%

52-Week Low$2.20

vGradeD

gGradeC

mGradeD

vgmGradeD

TLSI Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.15	-$0.16	-3.23%(-$0.01)
Q4 2025	Mar 5, 2026	-$0.13	-$0.05	+61.46%(+$0.08)
Q3 2025	Nov 13, 2025	-$0.17	-$0.87	-425.70%(-$0.70)
Q2 2025	Aug 12, 2025	-$0.22	-$0.23	-2.80%(-$0.01)

TLSI Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.09

4.10

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
TLSITriSalus Life Sciences, Inc. Common Stock	D	C	D	5.0x	—	85.8%	-67.7%	$3.63
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About TriSalus Life Sciences, Inc. Common Stock

TriSalus Life Sciences develops drug delivery systems and immune-oncology therapeutics for difficult-to-treat hepatocellular and pancreatic cancers. The company commercializes PEDD infusion systems through its TriNav platform with SmartValve technology, while advancing the investigational agent nelitolimod (SD-101) to enhance immune response in liver and pancreatic cancer patients.

TLSI Next Earnings Report

Report dateNov 12, 2026

QuarterQ3 2026

Report timeAMC

Revenue estimate$14.02M

Also reporting on Nov 12, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

TLSI Insider Transactions

SellOct 5, 2026
MARSHAK RICHARD
Officer
Shares: 325Value: $1,427
SellOct 5, 2026
STEVENS JENNIFER
Officer
Shares: 316Value: $1,387
SellOct 5, 2026
COX BRYAN F
Officer
Shares: 296Value: $1,299

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for October 2026

Companies in Related Industries

NAUTNautilus Biotechnolgy, Inc. Common StockLab Analytical Instruments
EYPTEyePoint, Inc. Common StockLab Analytical Instruments
QSIQuantum-Si Incorporated Class A Common StockMeasuring & Controlling Devices
ELMDElectromed, Inc.Electromedical Equipment
GPROGoPro, Inc.Photographic Equipment & Supplies
FOCLEDAP TMS S.A. American Depositary SharesElectromedical Equipment
RXSTRxSight, Inc. Common StockOphthalmic Goods
INGNInogen IncOrthopedic & Prosthetic Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$2.20

High$7.95